Acta Dermato-Venereologica - Staphylococcal Scalded Skin Syndrome Caused by a Rare Variant of Exfoliative-toxin-A+ S. aureus in an Adult Immunocompromised Woman - HTML
Content » Vol 98, Issue 1

Short communication

Staphylococcal Scalded Skin Syndrome Caused by a Rare Variant of Exfoliative-toxin-A+ S. aureus in an Adult Immunocompromised Woman

Simona Saluzzo1, Franziska Layer2, Georg Stingl1# and Georg Stary1#

1Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases, Medical University of Vienna, AT-1090 Vienna, Austria, and 2Department of Infectious Diseases, National Reference Centre for Staphylococci and Enterococci, Division Nosocomial Pathogens and Antibiotic Resistances, Robert Koch Institute, Wernigerode, Germany. E-mail: simona.saluzzo@meduniwien.ac.at

#These authors contributed equally.

Accepted Aug 29, 2017; Epub ahead of print Aug 30, 2017

INTRODUCTION

Staphylococci may cause severe infections in children and immunocompromised adults (1). Staphylococcal scalded skin syndrome (SSSS), for example, is a potentially life-threatening disease caused by the haematogenous spread of exfoliative toxins (ET) of Staphylococcus aureus termed ET-A, ET-B or ET-D (2) and encoded by the respective chromosomal (eta, etd) and plasmid located genes (etb) (3); bullous impetigo (BI), on the other hand, results from the local impact of the very same exfoliatins. We report here a case of a SSSS caused by a rare ET-A-producing S. aureus strain in an adult woman affected by chronic lymphocytic B-cell leukaemia (CLBCL).

CASE REPORT

A 63-year-old woman presented with fever and a bullous skin eruption. She reported the intake of antibiotics one week earlier (amoxicillin and sulbactam) because of an upper airway infection. Her past medical history was remarkable for CLBCL, currently being treated with Ibrutinib. The patient had vesiculobullous lesions on an inflamed basis on her face, neck, trunk and left arm (Fig. 1A, B). Only a few blisters were intact; most were ruptured. Differential diagnoses included SSSS, a generalized variant of BI, toxic epidermal necrolysis (TEN), pemphigus vulgaris (PV) and toxic erythema of chemotherapy (TEC).


Fig. 1. Clinical course. (A) Flaccid bullae formation of face, neck, trunk and left arm. (B) Twenty days after initiation of antimicrobial therapy, lesions were healed without scarring. A written permission from the patient is given.

Physical examination revealed fever (38°C) and crepitation on thorax auscultation. A chest X-ray was diagnostic for pneumonia of the left lower lobe. The Tzanck test from a bullous lesion showed acantholytic cells with no sign of necrosis, making TEN unlikely. The Nikolsky sign was positive on clinically normal-appearing skin. Primary laboratory findings revealed elevated C-reactive protein of 20.88 mg/dl (normal < 0.5) and 9% relative band neutrophils (normal 3.0–5.0%). We observed hypoimmunoglobulinaemia, with IgG 340.0 mg/dl (normal 700–160), IgA 28.5 mg/dl (normal 70–400) and IgM 6.6 mg/dl (NR, 40–230).

Perilesional histology of a fresh bulla showed a neutrophilic infiltrate in the upper dermis, spongiosis and acantholytic split formation in the stratum granulosum (Fig. 2A). A search for pemphigus antibodies yielded negative results. A gram stain of lesional skin revealed gram+ cocci in the split (Fig 2B). Bacterial cultures from blood and sputum, as well as swabs of the nose and lesional skin, were positive for methicillin-sensitive S. aureus (MSSA). DNA sequencing of the S. aureus-specific staphylococcal protein A (spa) and multi-locus sequence-typing (MLST) revealed spa-type t729, sequence type (ST) 88 for all isolates. Strains were positive for the gene encoding the exfoliative toxin A (eta). A diagnosis of SSSS was made and the patient received intravenous piperacillin-sulbactam (4.5 g i.v. 3 times daily for 10 days) until complete remission (Fig. 1B).


Fig. 2. Perilesional histology of a fresh blister. (A) Haematoxylin and eosin (H&E) stain of a paraffin-embedded skin biopsy (upper left). Higher magnification reveals an exposed granular layer (upper right), spongiosis and subcorneal split formation (lower left), as well as a dense neutrophilic infiltration of the papillary dermis (lower right). (B) Gram stain of the skin biopsy showing Gram-positive cocci.

DISCUSSION

ET-A producing MSSA with spa-type t729/ST88 are ex- tremely rare in Europe. The National Reference Center for Staphylococci and Enterococci in Germany reported 68 cases of SSSS in the period 2014–2015, among which none of the ET-A-positive S. aureus strains were affiliated with spa-type t729. A French study of 349 cases of SSSS (in the period 1997–2007) reported no t729 strain (4). Among S. aureus nasal carriage studies performed in Germany and the Netherlands, only one strain with similar characteristics was reported in the community (5).

S. aureus strains ST88 are found more frequently in African countries and, in addition to MSSA, methicillin- resistant isolates are also reported (6).

The occurrence of SSSS in our patient was probably not fortuitous. Recent evidence suggests an impaired bactericidal function of polymorphonuclear cells in patients affected by CLL (7), potentially explaining the susceptibility to gram+ septicaemia. Moreover, an impaired humoral response favours the septic spread of S. aureus both in children and immunocompromised adults (8). Therapeutic strategies to cure SSSS using intravenous immunoglobulins or direct elimination of the Toxin via Plasma exchange have proved successful (9, 10). A recent report suggests a role of Langerhans cells in providing a pre-emptive humoral protection against surface exfoliatin toxins, even before they can breach the tight junction causing systemic disease (11). Topical vaxination strategier that take advantage of antigen presentation through tight junktion by Langerhans cells might be useful in reducing the incidence of SSSS in immunocompromised patients and children.

REFERENCES
  1. Kjellander C, Björkholm M, Källman O, Giske CG, Weibull CE, Löve TJ, et al. Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study. Ann Hematol 2016; 95: 871–879.
    View article    Google Scholar
  2. Stanley JR, Amagai M. Mechanisms of disease pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006; 355: 1800–1810.
    View article    Google Scholar
  3. Bukowski M, Wladyka B, Dubin G. Exfoliative toxins of Sta­phylococcus aureus. Toxins 2010; 2: 1148–1165.
    View article    Google Scholar
  4. Lamand V, Dauwalder O, Tristan A, Casalegno JS, Meugnier H, Bes M, et al. Epidemiological data of staphylococcal scalded skin syndrome in France from 1997 to 2007 and microbiological characteristics of Staphylococcus aureus associated strains. Clin Microbiol Infect 2012; 18: E514–E521.
    View article    Google Scholar
  5. Donker GA, Deurenberg RH, Driessen C, Sebastian S, Nys S, Stobberingh EE. The population structure of staphylococcus aureus among general practice patients from The Netherlands. Clin Microbiol Infect 2009; 15: 137–143.
    View article    Google Scholar
  6. Breurec S, Zriouil SB, Fall C, Boisier P, Brisse S, Djibo S, et al. Epidemiology of methicillin-resistant Staphylococcus aureus lineages in five major African towns: emergence and spread of atypical clones. Clin Microbiol Infect 2011; 17: 160–165.
    View article    Google Scholar
  7. Kontoyiannis DP, Georgiadou SP, Wierda WG, Wright S, Albert ND, Ferrajoli A, et al. Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia. Leuk Lymphoma 2013; 54: 1730–1733.
    View article    Google Scholar
  8. Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol 2014; 28: 1–6.
    View article    Google Scholar
  9. Kato T, Fujimoto N, Nakanishi G, Tsujita Y, Matsumura K, Eguchi Y, Tanaka T. Adult staphylococcal scalded skin syndrome successfully treated with plasma exchange. Acta Derm Venereol 2015; 95: 612–613.
    View article    Google Scholar
  10. Urata T, Kono M, Ishihara Y, Akiyama M. Adult staphylococcal scalded skin syndrome successfully treated with multimodal therapy including intravenous immunoglobulin. Acta Derm Venereol Acta Derm Venereol 2017 Aug 17. [Epub ahead of print].
    View article    Google Scholar
  11. Ouchi T, Kubo A, Yokouchi M, Adachi T, Kobayashi T, Kitashima DY, et al. Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome. J Exp Med 2011; 208: 2607–2613.
    View article    Google Scholar